Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Using new therapeutics that block the PD-L1:PD-1 interaction has proven successful in the clinic for many cancer types and has sparked great interest in the field of cancer immunotherapy
Siglec-15 may represent a novel class of immune inhibitors with tumor-associated expression and divergent mechanisms of action to PD-L1
application dilution species IP 1:25 WB 1:1000 IHC-P 1:500
allowing more accurate predictions of efficacy or toxicity of drug treatments
Synonym IL7
Galectin-3 Recombinant Rabbit mAb (SDT-370-111) Drug Target Proteins Using new therapeutics that blockProduct Specification Host Rabbit Antigen Galectin 3 Synonyms Gal 3, 35 kDa lectin, CBP 35, Galactose specific lectin 3, GALBP, IgE binding protein, L 31, Laminin binding protein, Lectin L 29, Mac 2 antigen Immunogen Recombinant Protein Location Cytoplasm, Nucleus, Secreted Accession P17931 Clone Number SDT 370 111 Antibody Type Rabbit mAb Application WB, IHC P, ICC, IP Reactivity Hu Purification Protein A Concentration 0. 25 mg ml Conjugation
US$ 39.00
US$ 12079.47
US$ 13.95
US$ 11.75